Scarica l'app Stockscreener
1.46
0.00%
0.00
Dopo l'orario di chiusura:
1.37
-0.09
-6.16%
Precedente Chiudi:
$1.46
Aprire:
$1.45
Volume 24 ore:
206.11K
Relative Volume:
0.37
Capitalizzazione di mercato:
$5.87M
Reddito:
-
Utile/perdita netta:
$-7.10M
Rapporto P/E:
-0.2752
EPS:
-5.3059
Flusso di cassa netto:
$-8.30M
1 W Prestazione:
+30.36%
1M Prestazione:
+9.77%
6M Prestazione:
+15.87%
1 anno Prestazione:
-75.59%
Intervallo 1D:
$1.30
$1.55
Intervallo di 1 settimana:
$1.08
$1.62
Portata 52W:
$0.9509
$6.2248
Dermata Therapeutics Inc Stock (DRMA) Company Profile
Nome
Dermata Therapeutics Inc
Settore
Industria
Telefono
(858)-223-0882
Indirizzo
3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO
Compare DRMA vs VRTX, REGN, ARGX, RVMD, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DRMA
Dermata Therapeutics Inc
|
1.46 | 5.87M | 0 | -7.10M | -8.30M | -5.3059 |
VRTX
Vertex Pharmaceuticals Inc
|
515.55 | 128.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
805.93 | 82.72B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
987.84 | 53.26B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
212.00 | 43.66B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
362.51 | 39.31B | 5.76B | 514.49M | 1.10B | 4.4813 |
Dermata Therapeutics Inc Borsa (DRMA) Ultime notizie
Dermata (NASDAQ: DRMA) ends Nasdaq listing for warrants - Stock Titan
Dermata Therapeutics raises $3.4 million in private placement - Investing.com
Dermata Therapeutics Announces Private Placement to Fund DTC Pivot - tipranks.com
Dermata Therapeutics raises $3.4 million in private placement By Investing.com - Investing.com Canada
Form 8K Dermata Therapeutics Inc For: 17 August By Investing.com - Investing.com India
Dermata Therapeutics Announces $3.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules - ACCESS Newswire
Dermata Therapeutics Raises $3.2 Million in Private Placement; Investors Get Resale Rights - TradingView
Why CoreWeave Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket - Sahm
DRMA|Dermata Therapeutics Inc|Price:1.370|Chg%:+0.290 - TradingKey
Dermata Therapeutics Stock Surges 27% Pre-Market: Why is it Moving? - webull.com
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Unusual volume stocks are being observed in Wednesday's session. - ChartMill
The market is filled with gapping stocks in Wednesday's session. - ChartMill
DRMA Stock In Focus As Dermata Pivots To Direct-To-Consumer Skincare - timothysykes.com
DRMA Stock Draws Traders As Dermata Pivots To Skincare - StocksToTrade
Went from a daytrader to a swing trader just like that... - Moomoo
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
DRMA Stock Draws Traders As Dermata Pivots To Skincare Launch - StocksToTrade
DERMATA THERAPEUTICS ($DRMA) Releases Q2 2026 Earnings, Stock Rises - Quiver Quantitative
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Dermata Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Trending Stocks Today | Dermata Therapeutics Soars 35.18% Post-Market - Moomoo
DRMA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Dermata Therapeutics (DRMA) faces going concern warning amid higher losses and cash burn - Stock Titan
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Second Quarter 2026 - ACCESS Newswire
Dermata's Tome Skincare Product Is Designed for Once-Weekly Use - Stock Titan
$Dermata Therapeutics (DRMA.US)$ - Moomoo
Dermata Therapeutics Inc expected to post a loss of 55 cents a shareEarnings Preview - TradingView
Dermata Therapeutics Inc (NASDAQ: DRMA) Share Price, DRMA Stock News, DRMA Share Price & Updates - Kalkine
Dermata Therapeutics Announces Commercial Launch Date for Tome(TM) Foundational Treatment - webull.com
Dermata Therapeutics Launches Tome Foundational Skincare Line - TipRanks
Dermata to launch first consumer skincare product Aug. 25 - Investing.com
Dermata to launch first consumer skincare product Aug. 25 By Investing.com - Investing.com South Africa
Dermata’s First Consumer Brand Wants to Function as ‘Microneedling Lite’ - WWD
Dermata Therapeutics, Inc. Revenue Breakdown – NASDAQ:DRMA - TradingView
Dermata Therapeutics Inc (DRMA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
DRMA|Dermata Therapeutics Inc|Price:1.290|Chg%:-0.030 - TradingKey
Dermata Therapeutics Inc (DRMA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Dermata Therapeutics, Inc. Revenue Breakdown – BOATS:DRMA - TradingView
Dermata Therapeutics Inc (DRMA) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
TradingKey - TradingKey
Dermata Therapeutics, Inc. Revenue Breakdown – BOATS:DRMAW - TradingView
Price to earnings forward of Dermata Therapeutics, Inc. – NASDAQ:DRMAW - TradingView
Price to sales forward of Dermata Therapeutics, Inc. – NASDAQ:DRMAW - TradingView
Enterprise value to revenue forward of Dermata Therapeutics, Inc. – NASDAQ:DRMAW - TradingView
Price to book forward of Dermata Therapeutics, Inc. – NASDAQ:DRMAW - TradingView
Dermata Therapeutics (DRMA) Drops 7.5% as Stock Nears Support at $1.23Analyst Upgrade Stocks - dars.gov.et
DRMA Q1 2026 Earnings: EPS Surprise of 11.21% Beats Estimates Amid No Revenue GenerationDividend Earnings Report - dars.gov.et
Dermata Therapeutics Warrants Hold at $0.01 Amidst Minimal ActivityUnusual Call Volume - dars.gov.et
Dermata Therapeutics Inc Warrant 2021- on Dermata Therapeutics Financial Disclosures & SEC Filings - TradingView
Dermata Therapeutics Warrant (DRMAW) Holds at $0.01 – Warrants Remain at Key Support LevelCombination Correction - dars.gov.et
Dermata Therapeutics Inc Azioni (DRMA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Dermata Therapeutics Inc Azioni (DRMA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Bedoya-Toro Munera Maria E | SVP, Regulatory Affairs |
Feb 17 '26 |
Buy |
1.27 |
1,000 |
1,270 |
1,012 |
1.80%
1.77%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):